drugset / Trial / NCT01023295
Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of this study is to examine effects of fosbretabulin tromethamine (fosbretabulin) on PCV as reflected by a change from baseline in the number of polypoid lesions on indocyanine green angiography (ICGA).
Timeline
- Start
- 2009-07
- Primary completion
- 2010-08
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fosbretabulin | Small molecule | 15 mg/m2 | Intravenous |
| Subject | fosbretabulin | Small molecule | 25 mg/m2 | Intravenous |
| Subject | fosbretabulin | Small molecule | 35 mg/m2 | Intravenous |
| Subject | fosbretabulin | Small molecule | 45 mg/m2 | Intravenous |